IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Evoq Remedies IPO offer price is ₹ 27.00 and got listed at ₹ 23.75. Read IPO details mentioned above.
Evoq Remedies IPO listing price is ₹ 23.75, issue price is ₹ 27.00, and currently trading at ₹ 3.25 as on 5 march 2025. Infraprime Logistics IPO performance is show below with lates CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Evoq Remedies IPO is a Fixed Price listing on BSE SME exchange. The company is based in Ahmedabad and caters to Pharmaceutical sector. Swastika Investmart is the merchant banker of Evoq Remedies IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 24th February 2022.
Evoq Remedies IPO offer price is ₹ 27.00 and got listed at ₹ 23.75. Read Infraprime Logistics Technologies IPO details mentioned above.Evoq Remedies IPO, based in Ahmedabad, operates in the Pharmaceutical sector with a focus on Trading house of Pharmaceuticals Raw Materials. The company is launching its SME IPO on the BSE SME exchange, using the Fixed Price Issue method. Evoq Remedies IPO size is ₹ 9.72 Cr. with fresh issue size of ₹ 9.72 Cr. and Offer for sale being Nil
The IPO allotment date for Evoq Remedies IPO is expected to be 25th March 2022, after the finalization of basis of allotment. Investors can check Evoq Remedies IPO allotment status on the registrars website, Bigshare Services Private Limited. Evoq Remedies IPO refund dates are 28th March 2022.
Evoq Remedies IPO is expected to be listed on 30th March 2022.
The upper price band for the Evoq Remedies IPO is set at ₹ 27.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Evoq Remedies IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Evoq Remedies IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 22nd March 2022. After submission, funds are blocked until the basis of allotment of Evoq Remedies IPO is finalised.
The merchant banker for Evoq Remedies IPO is Swastika Investmart Limited . Swastika Investmart Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Evoq Remedies IPO RHP for further details.
The registrar for Evoq Remedies IPO is Bigshare Services Private Limited. Investors can go to Bigshare Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Evoq Remedies IPO through their official website or helpline.
Evoq Remedies IPO was subscribed 1.67 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Listing Gain
Issue Price vs Listing Price:Market Performance
Issue Price vs CMP:Evoq Remedies IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Evoq Remedies Financial Review Page
Merchant Banker(s) of Evoq Remedies IPO: Swastika Investmart Limited
Evoq Remedies IPO subscription was 1.67 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Evoq Remedies IPO listed at a listing price of 23.75 against the offer price of 27.00.
The current market price of Evoq Remedies is 3.25.
Why Us?
